Event Description

The Solomon Center for Health Law and Policy welcomes you to join them for their first event of the year! This panel invited experts and change-makers from various backgrounds to discuss the therapeutic potential of psychedelics, and how to utilize collective action and coalition building to move access and innovation in the field forward.

Panelists

• Ismail Lourido Ali, J.D. (he/they), Director and Counsel for Policy & Advocacy, Multidisciplinary Association for Psychedelic Studies (MAPS)
• Congressman Earl Blumenauer (he/him), U.S. Representative for Oregon’s 3rd Congressional District
• Sharmin Ghaznavi, M.D., Ph.D. (she/her), Associate Director and Director of Cognitive Neuroscience, Center for the Neuroscience of Psychedelics
• Moderator: Mason Marks, M.D., J.D. (he/him), Senior Fellow and Project Lead on the Project on Psychedelics Law and Regulation, Petrie-Flom Center at Harvard Law School

Sponsored by the Solomon Center for Health Law and Policy, Yale Program for Psychedelic Medicine, Yale Pyschedelic Science Group, and Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.